Roblain, Q., Louis, T., Yip, C., Baudin, L., Struman, I., Caolo, V., LAMBERT, V., Lecomte, J.* , Noël, A.* , & Heymans, S.*. (2021). Intravitreal injection of anti-miRs against miR-142-3p reduces angiogenesis and microglia activation in a mouse model of laser-induced choroidal neovascularization. Aging, 13. doi:10.18632/aging.203035 Peer Reviewed verified by ORBi * These authors have contributed equally to this work. |
Colas, F., Zanda, B., Bouley, S., Jeanne, S., Malgoyre, A., Birlan, M., Blanpain, C., Gattacceca, J., Jorda, L., Lecubin, J., Marmo, C., Rault, J. L., Vaubaillon, J., Vernazza, P., Yohia, C., Gardiol, D., Nedelcu, A., Poppe, B., Rowe, J., ... Zollo, A. (01 December 2020). FRIPON: a worldwide network to track incoming meteoroids. Astronomy and Astrophysics, 644, 53. doi:10.1051/0004-6361/202038649 Peer Reviewed verified by ORBi |
LAMBERT, V.* , hansen, S.* , Schoumacher, M.* , Lecomte, J., Leenders, J., Hubert, P., Herfs, M., Blacher, S., Carnet, O., Yip, C., BLAISE, P., DUCHATEAU, E., LOCHT, B., THYS, M., CAVALIER, E., GOTHOT, A., Govaerts, B., RAKIC, J.-M., Noël, A.* , & De Tullio, P.*. (2020). Pyruvate dehydrogenase kinase/lactate axis: a therapeutic target for neovascular age-related macular degeneration identified by metabolomics. Journal of Molecular Medicine. doi:10.1007/s00109-020-01994-9 Peer Reviewed verified by ORBi * These authors have contributed equally to this work. |
Rech, M., Kuhn, A. R., Lumens, J., Carai, P., van Leeuwen, R., Verhesen, W., Verjans, R., Lecomte, J., Liu, Y., Luiken, J. J. F. P., Mohren, R., Cillero-Pastor, B., Heymans, S., Knoops, K., Van Bilsen, M., & Schroen, B. (01 March 2019). AntagomiR-103 and -107 Treatment Affects Cardiac Function and Metabolism. Molecular Therapy: Nucleic Acids, 14, 424-437. doi:10.1016/j.omtn.2018.12.010 Peer Reviewed verified by ORBi |
Kok, M., Nix, C., Nys, G., De Tullio, P., Lecomte, J., LAMBERT, V., & Fillet, M. (19 December 2018). Fluxomics of AMD using mass spectrometry from 10 µL of mice whole blood; investigation of DCA treatment [Poster presentation]. First CIRM Day. |
LAMBERT, V., Schoumacher, M., Lecomte, J., Arslan, D., Leenders, J., Govaerts, B., RAKIC, J.-M., Noël, A., & De Tullio, P. (19 September 2018). Metabolomics for the discovery of new therapeutic approach and personalized medicine: the case of exudative Age-related Macular Degeneration [Paper presentation]. Benelux metabolomics Days, Netherlands. |
Caolo, V., Roblain, Q., Lecomte, J., Carai, P., Peters, L., Cuijpers, I., Robinson, E. L., Derks, K., Sergeys, J., Noël, A., Jones, E. A. V., Moons, L., & Heymans, S. (2018). Resistance to retinopathy development in obese, diabetic and hypertensive ZSF1 rats: an exciting model to identify protective genes. Scientific Reports, 8 (1). doi:10.1038/s41598-018-29812-w Peer Reviewed verified by ORBi |
Berghmans, T., Scherpereel, A., Meert, A.-P., Giner, V., Lecomte, J., Lafitte, J.-J., Leclercq, N., Paesmans, M., Sculier, J.-P., Van Houtte, P., Roelandts, M., Thiriaux, J., Alexopoulos, C. G., Vaslamatzis, M., Holbrechts, S., Wackenier, P., Recloux, P., Bonduelle, Y., Corhay, J.-L., ... Steenhouwer, F. (19 September 2017). A Phase III randomized study comparing a chemotherapy with cisplatin and etoposide to a etoposide regimen without cisplatin for patients with extensive small-cell lung cancer. Frontiers in Oncology, 7 (SEP). doi:10.3389/fonc.2017.00217 Peer Reviewed verified by ORBi |
Carnet, O.* , Lecomte, J.* , Masset, A., Primac, I., Durré, T., Maertens, L., Detry, B., Blacher, S., Gilles, C., Péqueux, C., Paupert, J., Foidart, J.-M., Jerusalem, G., Cataldo, D., & Noël, A. (2015). Mesenchymal stem cells shed amphiregulin at the surface of lung carcinoma cells in a juxtacrine manner. Neoplasia, 17 (7), 552-63. doi:10.1016/j.neo.2015.07.002 Peer Reviewed verified by ORBi * These authors have contributed equally to this work. |
Maertens, L., Erpicum, C., Detry, B., Blacher, S., Lenoir, B., Carnet, O., Pequeux, C., Cataldo, D., Lecomte, J., Paupert, J., & Noël, A. (2014). Bone marrow-derived mesenchymal stem cells drive lymphangiogenesis. PLoS ONE, 9 (9), 106976. doi:10.1371/journal.pone.0106976 Peer Reviewed verified by ORBi |
LAMBERT, V., Lecomte, J., Hansen, S., Blacher, S., Alvarez Gonzalez, M.-L., Struman, I., Sounni, N. E., Rozet, E., De Tullio, P., Foidart, J.-M., Rakic, J.-M., & Noël, A. (2013). Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice. Nature Protocols, 8 (11), 2197-2211. doi:10.1038/nprot.2013.135 Peer Reviewed verified by ORBi |
Lecomte, J., Masset, A., Blacher, S., Maertens, L., Gothot, A., Delgaudine, M., Bruyere, F., Carnet, O., Paupert, J., Illemann, M., Foidart, J.-M., Lund, I. K., Hoyer-Hansen, G., & Noël, A. (2012). Bone Marrow-derived Myofibroblasts Are the Providers of Pro-invasive Matrix Metalloproteinase 13 in Primary Tumor. Neoplasia, 14 (10), 943-51. doi:10.1593/neo.121092 Peer Reviewed verified by ORBi |
Lecomte, J. (2011). Implication des cellules dérivées de la moelle osseuse en pathologies tumorale et oculaire [Doctoral thesis, Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/315299 |
Lecomte, J. (2011). Implication des cellules dérivées de la moelle osseuse en pathologie tumorale et oculaire [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/217773 |
Lecomte, J., Louis, K., Detry, B., Blacher, S., Lambert, V., Bekaert, S., Munaut, C., Paupert, J., Blaise, P., Foidart, J.-M., Rakic, J.-M., Krane, S. M., & Noël, A. (2011). Bone marrow-derived mesenchymal cells and MMP13 contribute to experimental choroidal neovascularization. Cellular and Molecular Life Sciences, 68, 677-686. doi:10.1007/s00018-010-0476-6 Peer Reviewed verified by ORBi |
Bruyere, F.* , Melen-Lamalle, L.* , Blacher, S., Detry, B., Masset, A., Lecomte, J., Lambert, V., Maillard, C., Hoyer-Hansen, G., Lund, L. R., Foidart, J.-M., & Noël, A. (2010). Does plasminogen activator inhibitor-1 drive lymphangiogenesis? PLoS ONE, 5 (3), 9653. doi:10.1371/journal.pone.0009653 Peer Reviewed verified by ORBi * These authors have contributed equally to this work. |
Castermans, K., Nguyen, N.-Q.-N., Lecomte, J., Noël, A., Martial, J., & Struman, I. (2009). The contribution of vasculogenesis to tumor neovascularization after angiostatic treatment [Poster presentation]. Giga cancer day, liège, Belgium. |
Noël, A., Jost, M., Lambert, V., Lecomte, J., & Rakic, J.-M. (August 2007). Anti-angiogenic therapy of exudative age-related macular degeneration: current progress and emerging concepts. Trends in Molecular Medicine, 13 (8), 345-352. doi:10.1016/j.molmed.2007.06.005 Peer Reviewed verified by ORBi |
Jost, M., Maillard, C., Lecomte, J., Lambert, V., Tjwa, M., Blaise, P., Alvarez Gonzalez, M.-L., Bajou, K., Blacher, S., Motte, P., Humblet, C., Defresne, M.-P., Thiry, M., Frankenne, F., Gothot, A., Carmeliet, P., Rakic, J.-M., Foidart, J.-M., & Noël, A. (2007). Tumoral and choroidal vascularization: differential cellular mechanisms involving plasminogen activator inhibitor type I. American Journal of Pathology, 171 (4), 1369-80. doi:10.2353/ajpath.2007.070074 Peer Reviewed verified by ORBi |
Jost, M., Maillard, C., Lambert, V., Tjwa, M., Blaise, P., Lecomte, J., Bajou, K., Blacher, S., Motte, P., Humblet, C., Defresne, M.-P., Thiry, M., Frankenne, F., Gothot, A., Carmeliet, P., Rakic, J.-M., Foidart, J.-M., & Noël, A. (2006). Plasminogen activator inhibitor type I (PAI-1) controls bone marrow-dependent and independent vascularization. Acta Clinica Belgica, 61 (2, MAR-APR), 87. Peer Reviewed verified by ORBi |
Jost, M., Maillard, C., Lecomte, J., Lambert, V., Tjwa, M., Blaise, P., Alvarez Gonzalez, M.-L., Bajou, K., Blacher, S., Motte, P., Humblet, C., Defresne, M.-P., Thiry, M., Frankenne, F., Gothot, A., Carmeliet, P., RAKIC, J.-M., Foidart, J.-M., & Noël, A. (2006). Plasminogen activator inhibitor type 1 (PAI-1) controls bone marrow-dependent and independent vascularization [Poster presentation]. Meeting ABEC/BVSK. |